Dilution profile // every instrument, one screen, from SEC filings

Sanara MedTech Inc. (SMTI)

CIK 714256 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGHS-3 on file 2024-05-21
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
HIGHwarrants = 187% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW+8% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
LOWoperating cash flow positive
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2020-11-132026-08-07

Latest: 9.2M shares as of Aug 7, 2026 (10-Q). Share count fell from 236.6M to 2.4M between Apr 1, 2019 and May 20, 2019, a pattern consistent with a reverse split (roughly 1-for-100); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Self-funding

profitable · generates cash

Full breakdown: cash runway tool · source filing →

Warrants

Warrants outstanding: 17.1M underlying shares, as reported Dec 31, 2012 (10-K).

Reported exercise price: $7.32 (aggregate figure as tagged; individual tranches vary).

Rough fully diluted estimate: 26.3M = 9.2M O/S + 17.1M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 11, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding9.2MAug 7, 2026
+ Warrants (aggregate, as tagged) (if exercised)17.1MDec 31, 2012
Fully diluted estimate26.3M+186.6% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

S-3May 21, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 0 executed · 0 registered.

EFFECTIVEMay 31, 2024SEC declared a registration effective — selling can beginEFFECT
REGISTEREDMay 21, 2024S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDAug 2, 2023Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDFeb 24, 2023Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
EXECUTEDJul 5, 2022Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDApr 8, 2022Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDApr 4, 2022Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDJul 19, 2021Unregistered share sale disclosed (8-K item 3.02)8-K
EXECUTEDFeb 16, 2021Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
EXECUTEDFeb 11, 2021Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
EFFECTIVEJan 4, 2021SEC declared a registration effective — selling can beginEFFECT
REGISTEREDDec 23, 2020S-3 registration — capacity to sell shares, not a sale yetS-3

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full SMTI workspace